Ezrin, more than a metastatic detERMinant?
Ezrin, more than a metastatic detERMinant? |
https://doi.org/10.18632/oncotarget.27227
Victoria Hoskin,
Abdi Ghaffari,
and Bruce E. Elliott
|
6755-6757 |
Aging and cancer: Is glucose a mediator between them?
Aging and cancer: Is glucose a mediator between them? |
https://doi.org/10.18632/oncotarget.27344
Alexey G. Golubev,
and Vladimir N. Anisimov
|
6758-6767 |
PTPRS drives adaptive resistance to MEK/ERK inhibitors through SRC
PTPRS drives adaptive resistance to MEK/ERK inhibitors through SRC |
https://doi.org/10.18632/oncotarget.27335
Thomas B. Davis,
Mingli Yang,
Heiman Wang,
Changgong Lee,
Timothy J. Yeatman,
and W. Jack Pledger
|
6768-6780 |
Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myeloma
Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myeloma |
https://doi.org/10.18632/oncotarget.27285
Simone Pacini,
Marina Montali,
Francesco Mazziotta,
Claudia P. Schifone,
Lucia Macchia,
Vittoria Carnicelli,
Francesca M. Panvini,
Serena Barachini,
Laura Notarfranchi,
Giovanni Battista Previti,
Gabriele Buda,
and Mario Petrini
|
6781-6790 |
NOTCH1 signaling in oral squamous cell carcinoma via a TEL2/SERPINE1 axis
NOTCH1 signaling in oral squamous cell carcinoma via a TEL2/SERPINE1 axis |
https://doi.org/10.18632/oncotarget.27306
Vasiliki Salameti,
Priyanka G. Bhosale,
Ashley Ames-Draycott,
Kalle Sipilä,
and Fiona M. Watt
|
6791-6804 |
Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer
Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer |
https://doi.org/10.18632/oncotarget.27308
Riki Okita,
Ai Maeda,
Katsuhiko Shimizu,
Yuji Nojima,
Shinsuke Saisho,
and Masao Nakata
|
6805-6815 |
Clinical utility of FDG-PET/CT for post-surgery surveillance of malignant pleural mesothelioma – Comparison with contrast-enhanced CT
Clinical utility of FDG-PET/CT for post-surgery surveillance of malignant pleural mesothelioma – Comparison with contrast-enhanced CT |
https://doi.org/10.18632/oncotarget.27324
Kazuhiro Kitajima,
Masaki Hashimoto,
Takayuki Katsuura,
Nobuyuki Kondo,
Toshiyuki Minami,
Kozo Kuribayashi,
Seiki Hasegawa,
Takashi Kijima,
and Koichiro Yamakado
|
6816-6828 |
Post-translational modifications of vimentin reflect different pathological processes associated with non-small cell lung cancer and chronic obstructive pulmonary disease
Post-translational modifications of vimentin reflect different pathological processes associated with non-small cell lung cancer and chronic obstructive pulmonary disease |
https://doi.org/10.18632/oncotarget.27332
Neel Ingemann Nissen,
Morten Karsdal,
and Nicholas Willumsen
|
6829-6841 |
Correction: Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1
Correction: Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1 |
https://doi.org/10.18632/oncotarget.27309
Kazumasa Sekihara,
Kaori Saitoh,
Lina Han,
Stefan Ciurea,
Shinichi Yamamoto,
Mika Kikkawa,
Saiko Kazuno,
Hikari Taka,
Naoko Kaga,
Hajime Arai,
Takashi Miida,
Michael Andreeff,
Marina Konopleva,
and Yoko Tabe
|
6842-6842 |
Correction: Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
Correction: Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer |
https://doi.org/10.18632/oncotarget.27311
Venkatrao Vantaku,
Sri Ramya Donepudi,
Chandrashekar R. Ambati,
Feng Jin,
Vasanta Putluri,
Khoa Nguyen,
Kimal Rajapakshe,
Cristian Coarfa,
Venkata Lokesh Battula,
Yair Lotan,
and Nagireddy Putluri
|
6843-6844 |